Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-10

Clinical Trial Update: Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of Dimebon in Alzheimer's disease patients. It evaluated Dimebon in combination with memantine and with memantine plus don…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimebon (latrepirdine)
  • Donepezil (donepezil)
  • Memantine (memantine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED